申请人:Ortega Muñoz Alberto
公开号:US20120264823A1
公开(公告)日:2012-10-18
The invention relates to compounds of Formula (I): (A′)
x
-(A)-(B)—(Z)-(L)-C(═O)NH
2
or pharmaceutically acceptable salts or solvates thereof, wherein: (A) is heteroaryl or aryl; each (A′), if present, is indepedently chosen from aryl, arylalkoxy, arylalkyl, heterocyclyl, aryloxy, halo, alkoxy, haloalkyl, cycloalkyl, haloalkoxy, and cyano, wherein each (A′) is substituted with 0, 1, 2 or 3 substituents independently chosen from halo, haloalkyl, aryl, arylalkoxy, alkyl, alkoxy, cyano, sulfonyl, sulfinyl, and carboxamide; X is 0, 1, 2, or 3; (B) is a cyclopropyl ring, wherein (A) and (Z) are covalently bonded to different carbon atoms of (B); (Z) is —NH—; and (L) is —(CH
2
)
m
CR
1
,R
2
—, wherein m is 0, 1, 2, 3, 4, 5, or 6, and wherein R
1
and R
2
are each independently hydrogen or C
1
-C
6
alkyl; provided that, if (L) is —CH
2
— or —CH(CH
3
)—, then X is not 0. The compounds of the invention are useful in the treatment of diseases such as cancer and neurodegenerative diseases.
本发明涉及式(I)的化合物:(A')x-(A)-(B)-(Z)-(L)-C(═O)NH2或其药学上可接受的盐或溶剂,其中:(A)是杂环芳基或芳基;每个(A')(如果存在)独立地选择自芳基,芳基烷氧基,芳基烷基,杂环芳基,芳氧基,卤素,烷氧基,卤代烷基,环烷基,卤代烷氧基和氰基,其中每个(A')都被0、1、2或3个取代基独立地取代,所述取代基独立地选择自卤素,卤代烷基,芳基,芳基烷氧基,烷基,烷氧基,氰基,磺酰基,磺酰亚基和羧酰胺;X为0、1、2或3;(B)为环丙基环,其中(A)和(Z)与(B)的不同碳原子共价键合;(Z)为—NH—;(L)为—(CH2)mCR1,R2—,其中m为0、1、2,3,4,5或6,R1和R2各自独立地为氢或C1-C6烷基;但如果(L)为—CH2—或—CH(CH3)—,则X不为0。本发明的化合物在治疗癌症和神经退行性疾病等疾病方面有用。